Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset

Cell Death and Disease

Volumn 2, Issue 11, 2011, Pages

  Maschietto, M ^a   Trape A P ^a,b   Piccoli, F S ^a   Ricca, T I ^a   Dias, A A M ^c   Coudry, R A ^a   Galante, P A ^d   Torres, C ^a   Fahhan, L ^b   Lourenco S ^a   Grundy, P E ^e   De Camargo, B ^f   De Souza, S ^d   Neves, E J ^b   Soares, F A ^a   Brentani, H ^b   Carraro, D M ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^e STOLLERY CHILDREN S HOSPITAL   (Canada)

^f INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Blastemal component; Gene expression; Kidney development; Wilms' tumor; Wnt signaling pathway

Indexed keywords

WNT PROTEIN; COMPLEMENTARY DNA; WNT5B PROTEIN, HUMAN;

ARTICLE; BLASTEMA; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEPHROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; ANIMAL; BIOSYNTHESIS; CELL STRAIN HEK293; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; KIDNEY TUMOR; METABOLISM; MOUSE; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT;

ANIMALS; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, WILMS TUMOR; HEK293 CELLS; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MICE; NUCLEIC ACID HYBRIDIZATION; SIGNAL TRANSDUCTION; WILMS TUMOR; WNT PROTEINS;

EID: 83155176084     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2011.105     Document Type: Article

References (39)

1. Schedl A. Renal abnormalities and their developmental origin. Nat Rev Genet 2007; 8: 791-802. (Pubitemid 47429212)
2. Dekel B, Metsuyanim S, Schmidt-Ott KM, Fridman E, Jacob-Hirsch J, Simon A et al. Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney. Cancer Res 2006; 66: 6040-6049.
3. Metsuyanim S, Harari-Steinberg O, Buzhor E, Omer D, Pode-Shakked N, Ben-Hur H et al. Expression of stem cell markers in the human fetal kidney. PLoS One 2009; 4: e6709.
4. Li CM, Guo M, Borczuk A, Powell CA, Wei M, Thaker HM et al. Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol 2002; 160: 2181-2190. (Pubitemid 34663409)
5. Li W, Kessler P, Williams BR. Transcript profiling of Wilms tumors reveals connections to kidney morphogenesis and expression patterns associated with anaplasia. Oncogene 2005; 24: 457-468. (Pubitemid 40188593)
6. Maschietto M, de Camargo B, Brentani H, Grundy P, Sredni S, Torres C et al. Molecular profiling of isolated histological components of Wilms tumor implicates a common role for the Wnt signaling pathway in kidney and tumor development. Oncology 2008; 75: 81-91.
7. Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer 2008; 8: 387-398. (Pubitemid 351589714)
8. Sredni S, Maschieto M, de Camargo B, Soares F. Myogenesis in Wilms tunors. Pediatric and Developmental Pathology 2004; 7: 668-669.
9. Fukuzawa R, Anaka MR, Weeks RJ, Morison IM, Reeve AE. Canonical WNT signalling determines lineage specificity in Wilms tumour. Oncogene 2009; 28: 1063-1075.
10. Fukuzawa R, Heathcott RW, Sano M, Morison IM, Yun K, Reeve AE. Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway. Pediatr Dev Pathol 2004; 7: 125-137. (Pubitemid 38715332)
11. Strutt D. Frizzled signalling and cell polarisation in Drosophila and vertebrates. Development 2003; 130: 4501-4513. (Pubitemid 37279405)
12. Tamimi Y, Ekuere U, Laughton N, Grundy P. WNT5A is regulated by PAX2 and may be involved in blastemal predominant Wilms tumorigenesis. Neoplasia 2008; 10: 1470-1480.
13. Rivera MN, Haber DA. Wilms' tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer 2005; 5: 699-712. (Pubitemid 41486363)
14. Koesters R, Niggli F, von Knebel Doeberitz M, Stallmach T. Nuclear accumulation of betacatenin protein in Wilms' tumours. J Pathol 2003; 199: 68-76. (Pubitemid 36054731)
15. Dressler GR, Douglass EC. Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc Natl Acad Sci USA 1992; 89: 1179-1183.
16. Discenza MT, He S, Lee TH, Chu LL, Bolon B, Goodyer P et al. WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2. Oncogene 2003; 22: 8145-8155. (Pubitemid 37487305)
17. Little SE, Hanks SP, King-Underwood L, Jones C, Rapley EA, Rahman N et al. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study. J Clin Oncol 2004; 22: 4140-4146. (Pubitemid 41185184)
18. Scott J, Cowell J, Robertson ME, Priestley LM, Wadey R, Hopkins B et al. Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues. Nature 1985; 317: 260-262. (Pubitemid 16246503)
19. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 1993; 362: 749-751. (Pubitemid 23125978)
20. Bjornsson HT, Brown LJ, Fallin MD, Rongione MA, Bibikova M, Wickham E et al. Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors. J Natl Cancer Inst 2007; 99: 1270-1273. (Pubitemid 47299905)
21. Natrajan R, Williams RD, Hing SN, Mackay A, Reis-Filho JS, Fenwick K et al. Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse. J Pathol 2006; 210: 49-58. (Pubitemid 44288180)
22. Gupta A, Kessler P, Rawwas J, Williams BR. Regulation of CRABP-II expression by MycN in Wilms tumor. Exp Cell Res 2008; 314: 3663-3668.
23. Li W, Kessler P, Yeger H, Alami J, Reeve AE, Heathcott R et al. A gene expression signature for relapse of primary Wilms tumors. Cancer Res 2005; 65: 2592-2601. (Pubitemid 40490057)
24. Calmon MF, Rodrigues RV, Kaneto CM, Moura RP, Silva SD, Mota LD et al. Epigenetic silencing of CRABP2 and MX1 in head and neck tumors. Neoplasia 2009; 11: 1329-1339.
25. Sessler RJ, Noy N. A ligand-activated nuclear localization signal in cellular retinoic acid binding protein-II. Mol Cell 2005; 18: 343-353. (Pubitemid 41350539)
26. Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, Bond M et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 2003; 9: 407-415. (Pubitemid 36460074)
27. Tanigawa S, Wang H, Yang Y, Sharma N, Tarasova N, Ajima R et al. Wnt4 induces nephronic tubules in metanephric mesenchyme by a non-canonical mechanism. Dev Biol 2011; 352: 58-69.
28. Williams RD, Hing SN, Greer BT, Whiteford CC, Wei JS, Natrajan R et al. Prognostic classification of relapsing favorable histology Wilms tumor using cDNA microarray expression profiling and support vector machines. Genes Chromosomes Cancer 2004; 41: 65-79. (Pubitemid 38988739)
29. Maschietto M, Piccoli FS, Costa CM, Camargo LP, Neves JI, Grundy PE et al. Gene expression analysis of blastemal component reveals genes associated with relapse mechanism in Wilms tumour. Eur J Cancer 2011; e-pub ahead of print 22 June 2011.
30. Brentani RR, Carraro DM, Verjovski-Almeida S, Reis EM, Neves EJ, de Souza SJ et al. Gene expression arrays in cancer research: methods and applications. Crit Rev Oncol Hematol 2005; 54: 95-105. (Pubitemid 40544947)
31. Carroll R, Schneider H. A note on Levene's tests for equality of variances. Stat Probab Lett 1995; 3: 191-194.
32. Mello BP, Abrantes EF, Torres CH, Machado-Lima A, Fonseca RaS, Carraro DM et al. No-match ORESTES explored as tumor markers. Nucleic Acids Res 2009; 37: 2607-2617.
33. Brentani H, Caballero OL, Camargo AA, da Silva AM, da Silva WA, Dias Neto E et al. The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc Natl Acad Sci USA 2003; 100: 13418-13423. (Pubitemid 37444757)
34. Camargo AA, Samaia HP, Dias-Neto E, Simão DF, Migotto IA, Briones MR et al. The contribution of 700, 000 ORF sequence tags to the definition of the human transcriptome. Proc Natl Acad Sci USA 2001; 98: 12103-12108. (Pubitemid 32959834)
35. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
36. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034.
37. Ricca TI, Liang G, Suenaga AP, Han SW, Jones PA, Jasiulionis MG. Tissue inhibitor of metalloproteinase 1 expression associated with gene demethylation confers anoikis resistance in early phases of melanocyte malignant transformation. Transl Oncol 2009; 2: 329-340.
38. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003; 4: P3.
39. Ferreira E, Maschietto M, Silva S, Brentani H, Carraro D. Evaluation of quantitative RTPCR using nonamplified and amplified RNA. Diagn Mol Pathol 2010; 19: 45-53.